Search - tctmd.com

Displaying 781 - 800 of 2029

Sort: Relevancy | Date

Presentation TCT 2014

Is Pro-healing a Valid Concept? The Sirolimus-Endothelial Progenitor Cell Antibody Combo Technology

Presenter: Marie-Claude Morice, Giulio G. Stefanini, Pedro A. Lemos, Michael Haude

September 15, 2014

Presentation TCT 2014

The Sirolimus-Eluting Stent-Balloon: Update of the Abluminus ABL-1 Study

Presenter: Alexandre Abizaid, Pieter C. Smits, Robert J. Gil, Sameer I. Dani

September 15, 2014

Presentation TCT 2014

Cobalt-Chromium Sirolimus-Eluting Platforms VII: MiStent

Presenter: Alexandre Abizaid, Pieter C. Smits, Robert J. Gil, John A. Ormiston

September 15, 2014

Presentation TCT 2014

Cobalt-Chromium Sirolimus-Eluting Platforms VI: Ultimaster

Presenter: Alexandre Abizaid, Pieter C. Smits, Robert J. Gil, Shigeru Saito

September 15, 2014

Presentation TCT 2014

Cobalt-Chromium Sirolimus-Eluting Platforms V: Alex Eluting Stent

Presenter: Alexandre Abizaid, Pieter C. Smits, Robert J. Gil

September 15, 2014

Presentation TCT 2014

Cobalt-Chromium Sirolimus-Eluting Platforms IV: Firehawk

Presenter: Alexandre Abizaid, Pieter C. Smits, Robert J. Gil, Bo Xu

September 15, 2014

Presentation TCT 2014

Cobalt-Chromium Sirolimus-Eluting Platforms III: Inspiron

Presenter: Alexandre Abizaid, Pieter C. Smits, Robert J. Gil, Pedro A. Lemos

September 15, 2014

Presentation TCT 2014

Cobalt-Chromium Sirolimus-Eluting Platforms II: ORSIRO

Presenter: Alexandre Abizaid, Pieter C. Smits, Robert J. Gil, Stephan Windecker

September 15, 2014

Presentation TCT 2014

Cobalt-Chromium Sirolimus-Eluting Platforms I: BioMime

Presenter: Alexandre Abizaid, Pieter C. Smits, Robert J. Gil, Ricardo A. Costa

September 15, 2014

Presentation TCT 2014

Novolimus-Eluting from a Bioabsorbable Polymer: Latest Update from EXCELLA II

Presenter: Alexandre Abizaid, Pieter C. Smits, Robert J. Gil, Stefan Verheye

September 15, 2014

Presentation TCT 2014

Platinum-Chromium Platform with Reduced Polymer Load and Rapid Bioabsorption: Everolimus-Eluting SYNERGY Program Update

Presenter: Alexandre Abizaid, Pieter C. Smits, Robert J. Gil, Ian T. Meredith

September 15, 2014

Presentation TCT 2014

TCT 584: Abluminal Biodegradable Polymer, Biolimus-Eluting Stent Versus Durable Polymer, Everolimus-Eluting Stent: 3-Year Follow-up from the COMPARE II Trial

Presenter: Alexandre Abizaid, Pieter C. Smits, Robert J. Gil

September 15, 2014

Presentation TCT 2014

TCT 652: Incidence and Predictors of Late Catch-up Phenomenon After Drug-Eluting Stent Implantation

Presenter: Alexandre Abizaid, Pieter C. Smits, Robert J. Gil, Masanobu Ohya

September 15, 2014

Presentation TCT 2014

Safety and Efficacy Profile of BioMatrix and Nobori in Simple and Complex Lesions: Global Program Overview

Presenter: Alexandre Abizaid, Pieter C. Smits, Robert J. Gil, Stephan Windecker

September 15, 2014

Presentation TCT 2014

Pro Durable Polymer-Based Metallic DES!

Presenter: Tullio Palmerini

September 15, 2014

Presentation TCT 2014

Pro Bioabsorbable Polymer-Based Metallic DES!

Presenter: Robert A. Byrne

September 15, 2014

Presentation TCT 2014

Bioabsorbable Polymer-Based Metallic DES: Technological and Biological Considerations

Presenter: Aloke V. Finn, Greg L. Kaluza, Robert J. Gil, Juan F. Granada

September 15, 2014

Presentation TCT 2014

TCT 270: Comparison Among a Drug-Eluting Balloon, Drug-Eluting Stent, and Plain Balloon Angioplasty for Treatment of In-Stent Restenosis: A Network Meta-analysis of 11 Randomized Controlled Trials

Presenter: John A. Bittl, Tullio Palmerini, Joo Myung Lee, MD

September 15, 2014

Presentation TCT 2014

Is There a Role for Cilostazol with Contemporary DES?

Presenter: Philip M. Urban, Marco Valgimigli, Christian M. Spaulding, Young-Hoon Jeong

September 14, 2014

Presentation TCT 2014

Is There a Preferential DES Type in Patients with Diabetes? Current Data and TUXEDO Trial Design

Presenter: Philip M. Urban, Marco Valgimigli, Christian M. Spaulding, Upendra Kaul

September 14, 2014

Advertisement

Is Pro-healing a Valid Concept? The Sirolimus-Endothelial Progenitor Cell Antibody Combo Technology

The Sirolimus-Eluting Stent-Balloon: Update of the Abluminus ABL-1 Study

Cobalt-Chromium Sirolimus-Eluting Platforms VII: MiStent

Cobalt-Chromium Sirolimus-Eluting Platforms VI: Ultimaster

Cobalt-Chromium Sirolimus-Eluting Platforms V: Alex Eluting Stent

Cobalt-Chromium Sirolimus-Eluting Platforms IV: Firehawk

Cobalt-Chromium Sirolimus-Eluting Platforms III: Inspiron

Cobalt-Chromium Sirolimus-Eluting Platforms II: ORSIRO

Cobalt-Chromium Sirolimus-Eluting Platforms I: BioMime

Novolimus-Eluting from a Bioabsorbable Polymer: Latest Update from EXCELLA II

Platinum-Chromium Platform with Reduced Polymer Load and Rapid Bioabsorption: Everolimus-Eluting SYNERGY Program Update

TCT 584: Abluminal Biodegradable Polymer, Biolimus-Eluting Stent Versus Durable Polymer, Everolimus-Eluting Stent: 3-Year Follow-up from the COMPARE II Trial

TCT 652: Incidence and Predictors of Late Catch-up Phenomenon After Drug-Eluting Stent Implantation

Safety and Efficacy Profile of BioMatrix and Nobori in Simple and Complex Lesions: Global Program Overview

Pro Durable Polymer-Based Metallic DES!

Pro Bioabsorbable Polymer-Based Metallic DES!

Bioabsorbable Polymer-Based Metallic DES: Technological and Biological Considerations

TCT 270: Comparison Among a Drug-Eluting Balloon, Drug-Eluting Stent, and Plain Balloon Angioplasty for Treatment of In-Stent Restenosis: A Network Meta-analysis of 11 Randomized Controlled Trials

Is There a Role for Cilostazol with Contemporary DES?

Is There a Preferential DES Type in Patients with Diabetes? Current Data and TUXEDO Trial Design

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content